Oncology leaders envision a future where cancer treatment will be more affordable, effective and less toxic. Advances in genomics and pharmacogenomics will lead to more specific and personalised treatments, with cancer detection often based on blood tests. New therapies will be developed, including antibody-drug conjugates and more effective immunotherapies. AI and machine learning will speed up the development of biomarkers for early detection, improving survival rates and quality of life. The goal is to shift the focus from treatment to precision detection and prevention.
Open source leaders are pushing for permanent government financing to maintain open source projects. They argue that as government oversight is vital to the national